Across TCGA pan-cancer cohorts, EIF4E2P1 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated EIF4E2P1 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher EIF4E2P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated EIF4E2P1 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

HNSC, ESCA, and KIRP are the cancer types where EIF4E2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	III,IV	1.000	0.573	.006	48	view →
ESCA	OS	Quartile	All	0.561	0.809	.001	46	view →
KIRP	DFS	Tertile	II,III,IV	0.122	0.626	.032	27	view →
OV	OS	Tertile	All	0.632	0.705	.036	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: EIF4E2P1 tumor-vs-normal RNA expression · all EIF4E2P1 data types